amifostine anhydrous has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Preisler, HD | 1 |
| Li, B | 1 |
| Yang, BL | 1 |
| Huang, RW | 1 |
| Devemy, E | 1 |
| Venugopal, P | 1 |
| Tao, M | 1 |
| Chopra, H | 1 |
| Gregory, SA | 1 |
| Adler, S | 1 |
| Sivaraman, S | 1 |
| Toofanfard, P | 1 |
| Jajeh, A | 1 |
| Galvez, A | 1 |
| Robin, E | 1 |
1 trial available for amifostine anhydrous and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Bone Marrow Cells; Cytokines; Female; fms-Like Tyrosine | 2000 |